Product
cobas® liat SARS-CoV-2 & Influenza A/B v2
cobas® liat SARS-CoV-2 & Influenza A/B v2 is a nucleic acid test from Roche Diagnostics, listed for SARS-CoV-2. Registration status and availability vary by market.
Loading
Loading
Search products, companies, tests, and guides — go from query to quote request in one place.
Product
cobas® liat SARS-CoV-2 & Influenza A/B v2 is a nucleic acid test from Roche Diagnostics, listed for SARS-CoV-2. Registration status and availability vary by market.
Product
cobas® liat SARS-CoV-2 v2 is a nucleic acid test from Roche Diagnostics, listed for SARS-CoV-2. Registration status and availability vary by market.
Product
cobas® MTB is a nucleic acid test from Roche Diagnostics, listed for Mycobacterium tuberculosis. Stated instrument compatibility: cobas® 5800, cobas® 6800, cobas® 8800. Registration status and availability vary by market.
Product
cobas® MTB-RIF/INH is a nucleic acid test from Roche Diagnostics, listed for Mycobacterium tuberculosis. Stated instrument compatibility: cobas® 5800, cobas® 6800, cobas® 8800. Registration status and availability vary by market.
Product
cobas® SARS-CoV-2 is a nucleic acid test from Roche Diagnostics, listed for SARS-CoV-2. Stated instrument compatibility: cobas® liat. Registration status and availability vary by market.
Product
cobas® SARS-COV-2 (cobas® 6800) is a qualitative nucleic acid test from Roche Diagnostics, listed for SARS-CoV-2. Stated instrument compatibility: cobas® 6800, cobas® 8800. Registration status and availability vary by market.
Product
cobas® SARS-CoV-2 & Influenza A/B is a nucleic acid test from Roche Diagnostics, listed for SARS-CoV-2. Stated instrument compatibility: cobas® liat. Registration status and availability vary by market.
Technology
Comparative genomic hybridization (CGH) is a technique that allows the detection of losses and gains in DNA copy number across the entire genome without prior knowledge of specific chromosomal abnormalities. Comparative genomic hybridization utilizes the hybridization of differentially labeled tumor and reference DNA to generate a map of DNA copy number changes in tumor genomes. Comparative genomic hybridization is an ideal tool for analyzing chromosomal imbalances in archived tumor material and for examining possible correlations between these findings and tumor phenotypes. (from Ried et al. J Mol Med 1997 75:801-14)
Technology
A system of (usually) epifluorescence light microscopy in which a fine laser beam of light is scanned over the object through the objective lens. The technique is particularly good at rejecting light from outside the plane of focus and so produces higher effective resolution than is normally achieved.
Company
Copan Diagnostics, Inc. is an IVD supplier based in United States, with a source-linked product portfolio. Molecular Diagnostics. Coverage spans Sample Preparation, Instruments | Bloodborne.
Company
diagnostic company involved in the manufacturing and marketing of in-vitro diagnostic reagents and instruments.
Company
are interested in becoming a distributor for Creative Diagnostics, please send an email with the following information to :